N-(2-(6-(4-cyclobutylamino-5-trifluoromethylpyrimidine-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl)-2-oxo-ethyl)acetamide

Preferred Label : N-(2-(6-(4-cyclobutylamino-5-trifluoromethylpyrimidine-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl)-2-oxo-ethyl)acetamide;

MeSH note : an aurora kinase inhibitor and antineoplastic agent; structure in first source;

CISMeF synonym : PF 03814735;

MeSH hyponym : PF03814735; PF-03814735;

Is substance : O;

Details

Origin ID

C550549;

UMLS CUI

C2935084;

MeSH indexing information
- protein kinase inhibitors [MeSH Descriptor]
MeSH term(s) associated for indexing
- heterocyclic compounds, 3-ring [MeSH Descriptor]
- pyrimidines [MeSH Descriptor]
Record concept(s)
- N-(2-(6-(4-cyclobutylamino-5-trifluoromethylpyrimidine-2-ylamino)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalen-9-yl)-2-oxo-ethyl)acetamide [MeSH concept]
- PF 03814735 [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients